We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
ARX-SACUBITRIL/VALSARTAN (Accelagen Pty Ltd)
Product name
ARX-SACUBITRIL/VALSARTAN
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
185 (255 working days)
Active ingredients
sacubitril, valsartan
Registration type
New generic medicine
Indication
[TRADE NAME] is indicated in adult patients for the treatment of chronic heart failure (NYHA Class II-IV) with reduced ejection fraction.